| 摘要 |
Use of 5-(w-aminoalkylamino)-isoxazole derivatives of formula (I), as well as their salts or esters, to treat diseases which respond to 5-HT receptor ligands: R1,R2 = H, alkyl, cycloalkyl, aryl or heteroaryl (optionally 1-3 fold substituted by alkyl, alkoxy, alkylthio, alkylsulphonyl, aryl, aryloxy, arylthio, arylsulphonyl, aralkyl, halo, CN, nitro, haloalkyl, alkoxycarbonyl, acyl, OH, COOH or NR7R8); R7,R8 = alkyl, aryl, arylsulphonyl, aralkyl, acyl or alkylsulphonyl; R3-R5 = H, alkyl, aryl, arylsulphonyl, heteroaryl, acyl or alkylsulphonyl (optionally 1-3 fold substituted as above); R6 = alkylene residue.
|
